Angela Sterious
Family · Naples, FLNPI 1952717415
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 169 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,526, 4.0 times the $632 reported in 2021. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $55.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Lilly USA, LLC$532
- Bayer$463
- Axsome Therapeutics, Inc.$396
- plus $4K from 32 others
What the payments were for
- Food & beverage$9,336100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $1,674 |
| Otsuka America Pharmaceutical, Inc. | 27 | $1,141 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $1,063 |
| Lilly USA, LLC | 8 | $532 |
| Bayer | 4 | $463 |
| Axsome Therapeutics, Inc. | 6 | $396 |
| Neurocrine Biosciences, Inc. | 3 | $369 |
| Teva Pharmaceuticals USA, Inc. | 5 | $325 |
| Johnson & Johnson | 10 | $311 |
| Corcept Therapeutics | 2 | $212 |
| Tris Pharma Inc | 3 | $200 |
| Boston Scientific | 2 | $173 |
| Insmed, Inc. | 2 | $170 |
| Biogen | 2 | $163 |
| Alkermes, Inc. | 4 | $162 |
| Teleflex LLC | 2 | $155 |
| Exact Sciences | 2 | $143 |
| Madrigal Pharmaceuticals | 1 | $140 |
| Astellas Pharma US Inc | 1 | $140 |
| Merck | 1 | $125 |
| AstraZeneca | 1 | $122 |
| Jazz Pharmaceuticals Inc. | 1 | $122 |
| GSK | 1 | $121 |
| Pfizer | 1 | $100 |
| Abiomed | 1 | $93 |
| Medtronic | 1 | $92 |
| Paratek Pharmaceuticals, Inc. | 1 | $91 |
| United Therapeutics Corporation | 1 | $86 |
| Sanofi-aventis U.S. LLC | 1 | $81 |
| Sunovion Pharmaceuticals Inc. | 4 | $79 |
| Neurelis, Inc. | 1 | $63 |
| Axonics, Inc. | 1 | $53 |
| Lundbeck LLC | 2 | $41 |
| Ironshore Pharmaceuticals Inc. | 2 | $41 |
| Almatica Pharma LLC | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Corium, LLC | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$872
- VRAYLAR$598
- Kerendia$463
- REXULTI$461
- VERQUVO$250
- Korlym$212
- ABILIFY MAINTENA$206
- REZDIFFRA$140
- Veozah$140
- INGREZZA$138
- MOUNJARO$125
- Skyrizi$123
- SUNOSI$122
- Quillivant$122
- Dyanavel XR$122
- Quillichew ER$122
- AREXVY$121
- Zurzuvae$120
- ZEPBOUND$118
- KISUNLA$117
How this compares
$9,336 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Other family in Naples
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.